1-7 of 7
Maria Jose Terol Castera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of the New Minion Chemistry and Duplex Basecalling for Immunoglobulin Gene Analysis in Chronic Lymphocytic Leukemia

Jordi Martinez-Serra, Julieta Nastasi, Blanca Ferrer Lores, Alicia Serrano-Alcalá, Adrian Moquera, Antonia Sampol Mayol, Maria Jose Terol Castera, Antonio Gutiérrez
Journal: Blood
Blood (2024) 144 (Supplement 1): 6765.
https://doi.org/10.1182/blood-2024-211399
Published: 2024
Journal Articles

The Addition of Brentuximab Vedotin to ESHAP Significantly Increases the Rate of Metabolic Complete Remissions Vs Chemotherapy Alone. in Patients with Relapsed/Refractory Classical Hodgkin's Lymphoma. Final Results of a Phase IIb Prospective Randomized Clinical Trial (BRESELIBET)

Anna Maria Sureda Balarí, Javier Nuñez Cespedes, María José Terol Castera, Francisca Maria Hernandez, Eva Domingo Domenech, Fatima De la Cruz Vicente, Miram Moreno, Elena Amutio, Ana Pilar Gonzalez, Raul Cordoba, Maria Carmen Martinez Munoz, Samuel Romero, Mariana Bastos-Oreiro, Antonia Rodriguez Izquierdo, Javier Briones, Richard Greil, Maria Casanova Espinosa, Araceli Rubio, Irit Avivi, Raquel Del Campo, Pilar Gómez, Theodoros P. Vassilakopoulos, Sandra Bašić-Kinda, Sotiros Papageorgiou, Victor Noriega Concepcion, Jose Sanchez Blanco, Blanca Sánchez-González, Izaskun Zeberio, Ramon García
Journal: Blood
Blood (2024) 144 (Supplement 1): 3049.
https://doi.org/10.1182/blood-2024-211527
Published: 2024
Journal Articles

Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy

Matthew G. Mei, Gaetano Corazzelli, Frank Morschhauser, Elizabeth Phillips, Graham P. Collins, Hun Ju Lee, Steve M Ansell, Craig H. Moskowitz, Nathalie A. Johnson, John Kuruvilla, Martin Hutchings, María José Terol Castera, George Hawkins, Anna Vossenkaemper, Teresa Collins, Robin Lesley, Emma Dean, Ting Yu, Connor Hall, Virginie Cerec, Pier Luigi Zinzani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4433.
https://doi.org/10.1182/blood-2023-180926
Published: 2023
Journal Articles

Digital PCR Assay for Evaluation of CD19-CAR-T Cells In Vivo Expansion in Aggressive B-Cell Lymphoma: Impact on Clinical Outcome

Laura Ventura, Alicia Serrano, Blanca Ferrer Lores, Rafael Hernani, Alexandru Robert Vasile Tudorache, Ana Isabel Teruel, Ana Saus Carreres, Alfonso Ortiz Algarra, Ignacio Arroyo Martin, Juan Carlos Hernandez Boluda, Jose Luis Pinana Sanchez, Ariadna Perez, Ana Benzaquen, Carlos Solano, Maria Jose Terol Castera
Journal: Blood
Blood (2023) 142 (Supplement 1): 7153.
https://doi.org/10.1182/blood-2023-188300
Published: 2023
Journal Articles

Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Jose Garcia-Marco, MD PhD, Patricia Baltasar Tello, Esther González Garcia, Dra., Eduardo Ríos Herranz, MD, Angel Ramirez Payer, María José Terol Castera, Diana Champ, Angeles Medina Perez, Mercedes Gironella, Alicia Rodríguez Fernández, Ana Muntañola Prat, Alexia Suárez Cabrera, Manuel Jurado Chacón, Miguel Fernández Zarzoso, Mercedes Rodríguez, Juana Clavel, Maria Victoria Dourdil Sahun, Christelle M Ferra Coll, Ernesto Pérez Persona, Carmen Milagros Marrero Santos, Rafael Forés, Julio Delgado, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4321.
https://doi.org/10.1182/blood.V130.Suppl_1.4321.4321
Published: 2017
Journal Articles

Response-Adapted Treatment with Rituximab/Bendamustine/Mitoxantrone/Dexamethasone and Maintenance Therapy with Rituximab in Patients with Follicular Lymphoma in Relapse or Refractory to First-Line Treatment with Immunochemotherapy. RBMDGELTAMO08 Trial

Francisco Javier Peñalver Párraga, José Antonio Márquez Navarro, Soledad Durán Nieto, Pilar Giraldo Castellano, Carlos Montalbán Sanz, María José Ramírez Sánchez, Juan-Manuel Sancho Cia, María José Terol Castera, Francisco Javier Capote Huelva, Antonio Gutiérrez García, Blanca Sánchez González, Antonio Salar Silvestre, Miguel Canales Albendea, MD PhD, María Dolores Caballero Barrigón
Journal: Blood
Blood (2016) 128 (22): 1788.
https://doi.org/10.1182/blood.V128.22.1788.1788
Published: 2016
Journal Articles

Prognostic Impact of the New CLL-IPI Index in a Single Center CLL Spanish Cohort

Blanca Ferrer Lores, MD, Blanca Navarro Cubells, PhD, Alicia Serrano Alcala, Biotechnologist, Ivan Castillo Martin, PhD, Anabel Teruel Casasus, MD, Sandra Ballester Martinez, PhD, Ariadna Perez Martinez, MD, Ana Mauricio Campos, MD, Inmaculada Castillo Valero, MD, Horacio Cano Gracia, MD, Carlos Solano Vercet, PhD, María José Terol Casterá, PhD
Journal: Blood
Blood (2016) 128 (22): 2019.
https://doi.org/10.1182/blood.V128.22.2019.2019
Published: 2016